Jundishapur Journal of Microbiology

Published by: Kowsar

Expression, Purification and Immunogenic Description of a Hepatitis C Virus Recombinant CoreE1E2 Protein Expressed by Yeast Pichia pastoris

Mehdi Fazlalipour 1 , Hossein Keyvani 1 , * , Seyed Hamid Reza Monavari 1 and Hamid Reza Mollaie 1
Authors Information
1 Department of Medical Virology, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: April 01, 2015, 8 (4); e17157
  • Published Online: April 18, 2015
  • Article Type: Research Article
  • Received: December 25, 2013
  • Revised: May 14, 2014
  • Accepted: July 26, 2014
  • DOI: 10.5812/jjm.8(4)2015.17157

To Cite: Fazlalipour M, Keyvani H, Monavari S H R, Mollaie H R. Expression, Purification and Immunogenic Description of a Hepatitis C Virus Recombinant CoreE1E2 Protein Expressed by Yeast Pichia pastoris, Jundishapur J Microbiol. 2015 ; 8(4):e17157. doi: 10.5812/jjm.8(4)2015.17157.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Keyvani H, Fazlalipour M, Monavari SH, Mollaie H. Hepatitis C Virus - Proteins, Diagnosis, Treatment and New Approach for Vaccine Development. Asian Pacific J Cancer Prev. 2012; 13(10): 4849-68
  • 2. Cai W, Su L, Liao Q, Ye L, Wu Y, Wu Z, et al. Expression, purification and immunogenic characterization of hepatitis C virus recombinant E1E2 protein expressed by Pichia pastoris yeast. Antiviral Res. 2010; 88(1): 80-5[DOI][PubMed]
  • 3. Lorent E, Bierau H, Engelborghs Y, Verheyden G, Bosman F. Structural characterisation of the hepatitis C envelope glycoprotein E1 ectodomain derived from a mammalian and a yeast expression system. Vaccine. 2008; 26(3): 399-410[DOI][PubMed]
  • 4. Carreno V, Bartolome J, Castillo I, Quiroga JA. New perspectives in occult hepatitis C virus infection. World J Gastroenterol. 2012; 18(23): 2887-94[DOI][PubMed]
  • 5. Akazawa D, Morikawa K, Omi N, Takahashi H, Nakamura N, Mochizuki H, et al. Production and characterization of HCV particles from serum-free culture. Vaccine. 2011; 29(29-30): 4821-8[DOI][PubMed]
  • 6. Martinez-Donato G, Capdesuner Y, Acosta-Rivero N, Rodriguez A, Morales-Grillo J, Martinez E, et al. Multimeric HCV E2 protein obtained from Pichia pastoris cells induces a strong immune response in mice. Mol Biotechnol. 2007; 35(3): 225-35[PubMed]
  • 7. Acosta-Rivero N, Rodriguez A, Musacchio A, Falcon V, Suarez VM, Martinez G, et al. In vitro assembly into virus-like particles is an intrinsic quality of Pichia pastoris derived HCV core protein. Biochem Biophys Res Commun. 2004; 325(1): 68-74[DOI][PubMed]
  • 8. Blanchard E, Brand D, Trassard S, Goudeau A, Roingeard P. Hepatitis C virus-like particle morphogenesis. J Virol. 2002; 76(8): 4073-9[PubMed]
  • 9. El-Awady MK, Tabll AA, El-Abd YS, Yousif H, Hegab M, Reda M, et al. Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goats. Virol J. 2009; 6: 66[DOI][PubMed]
  • 10. Houghton M, Abrignani S. Prospects for a vaccine against the hepatitis C virus. Nature. 2005; 436(7053): 961-6[DOI][PubMed]
  • 11. Martinez-Donato G, Acosta-Rivero N, Morales-Grillo J, Musacchio A, Vina A, Alvarez C, et al. Expression and processing of hepatitis C virus structural proteins in Pichia pastoris yeast. Biochem Biophys Res Commun. 2006; 342(2): 625-31[DOI][PubMed]
  • 12. Balamurugan V, Reddy GR, Suryanarayana VVS. Pichia pastoris: A notable heterologous expression system for the production of foreign proteins-Vaccines. Indian J Biotec. 2007; 6: 175-86
  • 13. Counihan NA, Rawlinson SM, Lindenbach BD. Trafficking of hepatitis C virus core protein during virus particle assembly. PLoS Pathog. 2011; 7(10)[DOI][PubMed]
  • 14. Feinstone SM, Hu DJ, Major ME. Prospects for prophylactic and therapeutic vaccines against hepatitis C virus. Clin Infect Dis. 2012; 55 Suppl 1-32[DOI][PubMed]
  • 15. Roldao A, Silva AC, Mellado MCM, Alves PM, Carrondo MJT. Viruses and virus-like particles in biotechnology: Fundamentals and applications.comprehensive biotechnology (Second Edition). 2011;
  • 16. Wang M, Jiang S, Wang Y. Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice. Biochem Biophys Res Commun. 2013; 430(1): 387-93[DOI][PubMed]
  • 17. Coimbra EC, Gomes FB, Campos JF, D'Arc M, Carvalho JC, Mariz FC, et al. Production of L1 protein from different types of HPV in Pichia pastoris using an integrative vector. Braz J Med Biol Res. 2011; 44(12): 1209-14[PubMed]
  • 18. Li Z, Hong G, Wu Z, Hu B, Xu J, Li L. Optimization of the expression of hepatitis B virus e gene in Pichia pastoris and immunological characterization of the product. J Biotechnol. 2008; 138(1-2): 1-8[DOI][PubMed]
  • 19. Stamataki Z, Coates S, Evans MJ, Wininger M, Crawford K, Dong C, et al. Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies. Vaccine. 2007; 25(45): 7773-84[DOI][PubMed]
  • 20. Johansson DX, Voisset C, Tarr AW, Aung M, Ball JK, Dubuisson J, et al. Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus. Proc Natl Acad Sci U S A. 2007; 104(41): 16269-74[DOI][PubMed]
  • 21. Kamili S, Drobeniuc J, Araujo AC, Hayden TM. Laboratory diagnostics for hepatitis C virus infection. Clin Infect Dis. 2012; 55 Suppl 1-8[DOI][PubMed]
  • 22. Vermehren J, Yu ML, Monto A, Yao JD, Anderson C, Bertuzis R, et al. Multi-center evaluation of the Abbott RealTime HCV assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C. J Clin Virol. 2011; 52(2): 133-7[DOI][PubMed]
  • 23. Acosta-Rivero N, Alvarez-Obregon JC, Musacchio A, Falcon V, Duenas-Carrera S, Marante J, et al. In vitro self-assembled HCV core virus-like particles induce a strong antibody immune response in sheep. Biochem Biophys Res Commun. 2002; 290(1): 300-4[DOI][PubMed]
  • 24. Klade CS, Schuller E, Boehm T, von Gabain A, Manns MP. Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination. Vaccine. 2012; 30(19): 2943-50[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments